Clinical Trials on Prostatic Disease in United States

Total 147964 results

Martha Mims

Recruiting

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer (APRE)

Prostate Cancer | Prostate Cancer Metastatic

United States
University of Alabama at Birmingham

Completed

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

Metastatic Prostate Cancer

United States
Mayo Clinic

Active, not recruiting

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer (DAPPER)

Malignant Prostate Neoplasm

United States
Weill Medical College of Cornell University

Completed

PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer (PRAGMA)

Metastatic Prostate Cancer

United States
Washington University School of Medicine

Recruiting

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Prostate Cancer | Prostate Neoplasm

United States
University of Southern California
National Cancer Institute (NCI); National Institute for Biomedical Imaging...

Terminated

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Prostate Neoplasm

United States
University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Recruiting

High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States
Roswell Park Cancer Institute
National Comprehensive Cancer Network

Recruiting

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8

United States
Memorial Sloan Kettering Cancer Center
Celgene Corporation

Completed

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Prostate Cancer | Castration Resistant Prostate Cancer

United States
University of California, San Francisco
National Cancer Institute (NCI); National Institute for Biomedical Imaging...

Recruiting

Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance

Prostate Cancer | Prostate Adenocarcinoma

United States
University of Colorado, Denver

Completed

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma

United States
James J. Peters Veterans Affairs Medical Center

Not yet recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Metastatic Cancer | Neoplasm, Prostate

United States
National Cancer Institute (NCI)

Completed

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Recurrent Prostate Cancer

United States
Profound Medical Inc.

Recruiting

Customized TULSA-PRO Ablation Registry (CARE)

Benign Prostatic Hyperplasia | Prostate Cancer | Prostate Adenocarcinoma

United States
National Cancer Institute (NCI)

Recruiting

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

Prostatic Neoplasms | Prostate Specific Antigens | Positive Digital Rectal Examination | Strong Family History of Prostate Cancer

United States
Case Comprehensive Cancer Center
National Institutes of Health (NIH)

Recruiting

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Prostate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of Prostate

United States
Gilead Sciences

Terminated

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

Metastatic Castrate-Resistant Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate Neoplasm

United States
Exosome Diagnostics, Inc.

Recruiting

ExoDx Prostate Evaluation in Active Surveillance Patient Population

Prostate Cancer

United States
Uro-1 Medical

Recruiting

Assessment of VMCore Biopsy Versus Standard of Care Biopsy

Prostate Cancer

United States
Matthew Gettman

Completed

Platelet Rich Plasma During Radical Prostatectomy

Prostate Cancer

United States
Dana-Farber Cancer Institute

Completed

A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy

Prostate Cancer

United States
Massachusetts General Hospital
Analogic Corporation

Completed

Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate

Prostate Cancer

United States
Case Comprehensive Cancer Center

Terminated

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Prostate Carcinoma

United States
Case Comprehensive Cancer Center

Completed

Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning

Prostate Cancer

United States
Stanford University

Terminated

Transrectal Photoacoustic Imaging of the Prostate

Prostate Cancer

United States
M.D. Anderson Cancer Center
Exelixis; High Impact Clinical Research Support Program

Completed

Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer

Prostate Cancer

United States
Perineologic

Completed

Prostate Biopsy Access Needle & Needle Guide Feasibility Study (STABLE)

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

MR Image Guided Therapy in Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States
Dana-Farber Cancer Institute
Sanofi

Completed

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

Prostate Cancer

United States
University of Hawaii
University of Hawaii Cancer Research Center

Terminated

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Regeneron Pharmaceuticals

Terminated

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Prostate Cancer

United States
Weill Medical College of Cornell University

Terminated

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Prostate Cancer

United States
Dana-Farber Cancer Institute

Completed

XL-184+Abiraterone in Post-Chemo CRPC

Prostate Cancer

United States
Nikkei (Canada) Marketing Limited

Withdrawn

Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate

Prostate Cancer

United States
NYU Langone Health

Completed

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer (SIBRT)

Prostate Cancer

United States
University of Missouri-Columbia

Withdrawn

Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy

Prostate Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

Prostate Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy

Prostate Cancer

United States
Emory University
United States Department of Defense

Completed

Improving Health Literacy in African-American Prostate Cancer Patients

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Progenics Pharmaceuticals, Inc.

Completed

Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer

Prostate Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment

Prostate Cancer

United States
Case Comprehensive Cancer Center

Completed

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

Prostate Cancer

United States
University of Wisconsin, Madison
Sanofi; Genzyme, a Sanofi Company

Terminated

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

Prostate Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Functional MRI Use in Prostate Radiation Treatment Planning

Prostate Cancer

United States
Case Comprehensive Cancer Center

Completed

Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening

Prostate Cancer

United States

Clinical Trials on Prostatic Disease in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations